October 08, 2020 09:00 - 10:15 EDT
In this five-part series we will bring together expertise from across the firm to cover developments that span the complete lifecycle of this industry’s complex business model—from financing and procurement to regulation and litigation.
Product liability litigation remains a challenging, business-critical risk for pharmaceutical and medical device manufacturers. Join Grant Worden, Sylvie Rodrigue and Nicole Mantini as they examine current and emerging trends relating to “mass torts”, the management of complex, multi-jurisdictional proceedings and copycat litigation from other jurisdictions. The panel will also review recent notable decisions and changes to Ontario’s Class Proceedings Act, and will discuss emerging issues for 2021 and beyond.
9:00 a.m. EDT Webinar opens
9:15 - 10:15 a.m. EDT Presentation
Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.
Sessions in this series:
Session 1: Navigating (and challenging) a changing life sciences regulatory environment
Session 2: Life sciences product liability litigation: managing risks and anticipating trends
Session 3: The latest developments in life sciences IP litigation
Session 4: Life sciences and centralized procurement: navigating the process and responding to RFPs
Session 5: Financing life sciences on both sides of the border